Transforming Vaccinology
Transforming Vaccinology
批准号:
9914468
负责人:
Thale Cross Jarvis
金额:
$1.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-02-24 至 2021-01-31
关键词:
AdjuvantAge-YearsAntibioticsAntigen-Antibody ComplexAntigensAntimicrobial ResistanceAutoimmune DiseasesChildChronicClinical TrialsCollaborationsCommunicable DiseasesCountryDevelopmentDiseaseEducational workshopElderlyExposure toFaceFosteringFoundationsFutureGenomicsHealthHumanImmunityImmunologyInfantInfectionItalyKnowledgeLearningLife ExpectancyMalignant NeoplasmsMedicalMethodologyMolecular StructureNatural ImmunityNeurodegenerative DisordersNucleic Acid VaccinesOutcomeParticipantPassive ImmunizationPhysiciansRNAResearchResearch PersonnelRoleScienceScientific Advances and AccomplishmentsScientistShapesStructureStructure of germinal center of lymph nodeSystems BiologyTechnologyThinkingTranslatingTranslationsTrustVaccinationVaccinesViral VectorWaterWorkage groupbaseclinical practicedesignfundamental researchimprovedinnovationinterestlow income countrymicrobiomemultidisciplinaryneglectnext generationnovel vaccinespostersprogramsscreeningsymposiumsynthetic biologyvaccine developmentvaccinology
中文摘要
摘要
要求为题为“转变疫苗学”的Keystone专题讨论会提供支助,
Drs.放大图片作者:Lynda M.斯图尔特和费德里卡·萨卢斯托。会议将于2015年10月21日至22日在意大利的佛罗伦萨举行。
2020年3月15日至19日。
沿着清洁的水和抗生素,疫苗接种使人类战胜了传染病
这曾导致50%的儿童死亡在上个世纪,疫苗接种也延长了寿命
预期寿命从50岁以下到80岁以上。现在最重要的婴儿疫苗和
疫苗接种面临着新的挑战,目的是将疫苗的好处带给儿童,
其他年龄组、新出现的感染、抗菌素耐药性、困扰低收入国家的疾病,以及
改善慢性传染病、癌症、自身免疫和神经退行性疾病的治疗
疾病这种新疫苗的雄心得到了科学技术令人难以置信的进步的支持,
使针对许多新目标的疫苗开发在技术上成为可能,并通过创新方法,
为新出现的感染和低收入国家的疾病开发疫苗。的科技
正在改变疫苗学的是基于结构的设计,佐剂,核酸疫苗(特别是RNA),
病毒载体、系统生物学和受控人类感染。它们得到了科学进步的支持,
人类免疫学、基因组学、合成生物学、抗原分子结构和抗原抗体
复合体、生发中心和微生物组。与会者将接触到多学科的
正在改变疫苗学的技术,包括CEPI,比尔和梅林达盖茨的努力
基金会和欢迎信托基金,以改变疫苗的开发方式。
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Transforming Vaccinology, organized by
Drs. Rino Rappuoli, Lynda M. Stuart and Federica Sallusto. The conference will be held in Florence, Italy from
March 15-19, 2020.
Along with clean water and antibiotics, vaccination has allowed mankind to conquer the infectious diseases
that used to eradicate about 50% of children. Over the last century, vaccination has also extended life
expectancy from under 50 to over 80 years of age. Now that the most important vaccines for infants and
children are available, vaccination faces new challenges with the intent to bring the benefits of vaccines to
other age groups, emerging infections, antimicrobial resistance, diseases that afflict low-income countries, and
to improve therapies against chronic infectious diseases, cancer, autoimmune and neurodegenerative
diseases. This new vaccine ambition is supported by the incredible advances in science and technology that
make it technically possible to develop vaccines against many new targets and by innovative approaches to
vaccine development for emerging infections and for diseases of low-income countries. The technologies that
are transforming vaccinology are structure-based design, adjuvants, nucleic acid vaccines (especially RNA),
viral vectors, systems biology, and controlled human infections. They are supported by scientific advances in
human immunology, genomics, synthetic biology, molecular structure of antigens and antigen-antibody
complexes, germinal centers, and microbiome. Conference participants will be exposed to the multidisciplinary
technologies that are transforming vaccinology, including the efforts of CEPI, Bill and Melinda Gates
Foundation and Welcome Trust, to change the way vaccines are developed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioenergetics in Health and Diseases
-
批准号:10609120
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Autophagy and Neurodegeneration: Mechanisms to Therapies
-
批准号:10608666
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Adipose Tissue: Energizing Good Fat
-
批准号:10609127
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Cancer Neoantigens, Vaccines and Viruses
-
批准号:10233861
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Small Regulatory RNAs: From Bench to Bedside
-
批准号:10462420
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Engineering Multi-Cellular Living Systems
-
批准号:10462913
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Gut-Brain Axis
-
批准号:10467819
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Malaria: Confronting Challenges From Drug Discovery to Treatment
-
批准号:10468493
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
The Human Microbiome: Ecology and Evolution
-
批准号:10391370
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
-
批准号:10468419
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Progress in Vaccine Development for Infectious Diseases
-
批准号:10467880
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies
-
批准号:10462412
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Drug Delivery to the Brain: Challenges and Progress
-
批准号:10540503
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neurocircuitry of Social Behavior
-
批准号:10540465
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Resolution of Inflammation
-
批准号:10469175
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Organoids as Tools for Fundamental Discovery and Translation
-
批准号:10469084
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Novel Approaches Against Emerging Antimicrobial Resistance
-
批准号:10391767
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Precision Genome Engineering
-
批准号:10391367
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neuronal Control of Appetite
-
批准号:10468571
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Innate Immunity: Complement and Beyond
-
批准号:10464340
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
海外基金